Real-time enrollment status for this mog antibody disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT05063162 |
| Recruiting Status | Active, Not Recruiting |
| Condition | MOG Antibody Disease |
| Phase | Clinical Trial |
| Target Enrollment | 104 participants |
| Active Locations | 15 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT05063162 is currently active_not_recruiting participants. This clinical trial study for mog antibody disease is not currently accepting new participants at 15 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05063162 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05063162 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.